MX373872B - Composiciones de isoxazolina y uso de las mismas en la prevención o tratamiento de infestaciones parasitarias en animales. - Google Patents

Composiciones de isoxazolina y uso de las mismas en la prevención o tratamiento de infestaciones parasitarias en animales.

Info

Publication number
MX373872B
MX373872B MX2016008118A MX2016008118A MX373872B MX 373872 B MX373872 B MX 373872B MX 2016008118 A MX2016008118 A MX 2016008118A MX 2016008118 A MX2016008118 A MX 2016008118A MX 373872 B MX373872 B MX 373872B
Authority
MX
Mexico
Prior art keywords
animals
prevention
treatment
parasite infestations
isoxazoline
Prior art date
Application number
MX2016008118A
Other languages
English (en)
Spanish (es)
Other versions
MX2016008118A (es
Inventor
Anne Lehay
Annie Flochlay-Sigognault
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2016008118A publication Critical patent/MX2016008118A/es
Publication of MX373872B publication Critical patent/MX373872B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/105Aliphatic or alicyclic compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • A23K20/132Heterocyclic compounds containing only one nitrogen as hetero atom
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • A23K20/137Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/30Feeding-stuffs specially adapted for particular animals for swines
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/70Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75Feeding-stuffs specially adapted for particular animals for birds for poultry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Wood Science & Technology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MX2016008118A 2013-12-20 2014-12-19 Composiciones de isoxazolina y uso de las mismas en la prevención o tratamiento de infestaciones parasitarias en animales. MX373872B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13199006 2013-12-20
PCT/EP2014/078634 WO2015091898A1 (en) 2013-12-20 2014-12-19 Isoxazoline compositions and use thereof in the prevention or treatment of parasite infestations in animals

Publications (2)

Publication Number Publication Date
MX2016008118A MX2016008118A (es) 2016-09-16
MX373872B true MX373872B (es) 2020-03-26

Family

ID=49880542

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016008118A MX373872B (es) 2013-12-20 2014-12-19 Composiciones de isoxazolina y uso de las mismas en la prevención o tratamiento de infestaciones parasitarias en animales.

Country Status (11)

Country Link
US (4) US10456358B2 (enExample)
EP (2) EP4306168B1 (enExample)
JP (1) JP6581586B2 (enExample)
CN (2) CN110327468B (enExample)
ES (2) ES3036365T3 (enExample)
HU (2) HUE066811T2 (enExample)
MX (1) MX373872B (enExample)
PL (2) PL3082867T3 (enExample)
PT (1) PT4306168T (enExample)
RU (1) RU2688919C1 (enExample)
WO (1) WO2015091898A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6581586B2 (ja) * 2013-12-20 2019-09-25 インターベット インターナショナル ベー. フェー. イソオキサゾリン組成物および動物における寄生虫侵襲の予防または処置におけるその使用
US20170232024A1 (en) 2014-08-04 2017-08-17 Jerry Tan Eye Surgery Pte Ltd Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
CA2971296A1 (en) * 2014-12-22 2016-06-30 Intervet International B.V. Use of isoxazoline compounds for treating demodicosis
CN107750159B (zh) * 2015-06-23 2021-10-29 英特维特国际股份有限公司 用于消毒的饮用水的含有维生素的异噁唑啉溶液
WO2018039508A1 (en) * 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
WO2018081733A1 (en) * 2016-10-31 2018-05-03 The California Institute For Biomedical Research Methods and compositions for preventing vector-borne disease transmission
PE20201150A1 (es) * 2017-11-07 2020-10-26 Intervet Int Bv Composiciones farmaceuticas inyectables de isoxazolina y usos de las mismas
AU2018363686B2 (en) * 2017-11-07 2023-11-23 Intervet International B.V. Process for preparing large size isoxazoline particles
CN119157876A (zh) * 2017-12-15 2024-12-20 塔苏斯制药有限公司 用于治疗睑炎的异恶唑啉驱虫剂制剂和方法
EP3726972A1 (en) 2017-12-20 2020-10-28 Intervet International B.V. Method and system for external fish parasite monitoring in aquaculture
US11533893B2 (en) 2017-12-20 2022-12-27 Intervet Inc. Method and system for external fish parasite monitoring in aquaculture
CN111511201A (zh) * 2017-12-20 2020-08-07 英特维特国际股份有限公司 用于水产养殖中的鱼外部寄生虫监测的系统
CN111491508B (zh) * 2017-12-20 2022-05-24 英特维特国际股份有限公司 用于水产养殖中的鱼外部寄生虫监测的系统
US11825814B2 (en) 2017-12-20 2023-11-28 Intervet Inc. System for external fish parasite monitoring in aquaculture
KR102142916B1 (ko) * 2018-08-17 2020-08-10 부산대학교 산학협력단 상향식 방법을 통한 난용성 약물을 포함하는 나노현탁액의 제조방법 및 이로 제조된 나노현탁액
US12502377B2 (en) 2019-04-04 2025-12-23 Tarsus Pharmaceuticals, Inc. Method of eradicating ticks that attach to humans using lotilaner formulations
US20220249445A1 (en) * 2019-06-19 2022-08-11 Tarsus Pharmaceuticals, Inc. Isoxazoline parasiticide formulations and methods for treating blepharitis
AU2020295570A1 (en) * 2019-06-19 2022-02-10 Tarsus Pharmaceuticals, Inc. Isoxazoline parasiticide formulations and methods for treating blepharitis
MX2022007455A (es) 2019-12-18 2022-08-15 Elanco Tiergesundheit Ag Derivados de isoxazolina como plaguicidas.
JP7724845B2 (ja) 2020-07-24 2025-08-18 エランコ・ユーエス・インコーポレイテッド イソオキサゾリン化合物及びその中間体を作製するための方法
KR20230061465A (ko) 2020-09-04 2023-05-08 엘랑코 유에스 인코포레이티드 기호성 제형
CA3211576A1 (en) * 2021-03-11 2022-09-15 In The Bowl Animal Health, Inc. Oral canine feed and methods for controlling tick infestations in a canine
KR20240051920A (ko) * 2021-06-25 2024-04-22 인 더 보울 애니멀 헬스, 인크. 고양잇과의 진드기 감염을 구제하기 위한 경구용 고양잇과 사료 및 방법
CN114306231B (zh) * 2021-12-29 2023-03-24 天津市中升挑战生物科技有限公司 一种氟雷拉纳杀虫剂及其制备方法和应用
CN117064851B (zh) * 2023-09-20 2026-02-17 中国农业大学 一种异噁唑啉类驱虫药制剂的制备方法
PL449854A1 (pl) * 2024-09-18 2026-03-23 Okoniewski Piotr Kompozycja farmaceutyczna, lecznicza woda pitna, ich zastosowanie i sposób wytwarzania leczniczej wody pitnej

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3727648A1 (de) 1987-08-19 1989-03-02 Bayer Ag Neue avermectin derivate, verfahren zu ihrer herstellung und ihre verwendung
US6998131B2 (en) * 1996-09-19 2006-02-14 Merial Limited Spot-on formulations for combating parasites
CN101768129B (zh) 2004-03-05 2012-05-23 日产化学工业株式会社 异*唑啉取代苯甲酰胺化合物的制备中间体
WO2007053902A1 (en) * 2005-11-10 2007-05-18 Bomac Animal Health Pty Limited Method of treating parasites
TW200803740A (en) 2005-12-16 2008-01-16 Du Pont 5-aryl isoxazolines for controlling invertebrate pests
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
HUE037127T2 (hu) 2007-06-27 2018-08-28 Du Pont Állati károkozó irtására szolgáló eljárás
TWI556741B (zh) * 2007-08-17 2016-11-11 英特威特國際股份有限公司 異唑啉組成物及其作為抗寄生蟲藥上的應用
TWI411395B (zh) 2007-12-24 2013-10-11 Syngenta Participations Ag 殺蟲化合物
WO2010003923A1 (en) * 2008-07-09 2010-01-14 Basf Se Pestcidal active mixtures comprising isoxazoline compounds i
CA2973871C (en) 2008-07-09 2019-09-10 Nissan Chemical Industries, Ltd. Production method of isoxazoline-substituted benzoic acid amide compound
SG171751A1 (en) * 2008-11-19 2011-07-28 Merial Ltd Compositions comprising an aryl pyrazole and/ or a formamidine methods and uses thereof
EP2379544B1 (en) 2008-12-18 2013-10-16 Novartis AG Isoxazolines derivatives and their use as pesticide
PL2379537T3 (pl) 2008-12-19 2013-03-29 Elanco Tiergesundheit Ag Pochodne izooksazoliny i ich zastosowanie jako pestycydów
ES2545738T3 (es) 2009-07-30 2015-09-15 Merial, Inc. Compuestos insecticidas a base de 4-amino-tieno[2,3-d]-pirimidina y procedimientos para su uso
AR081843A1 (es) 2010-06-09 2012-10-24 Syngenta Participations Ag Mezclas pesticidas incluyendo derivados isoxazolina
DK178277B1 (da) 2010-06-18 2015-10-26 Novartis Tiergesundheit Ag Diaryloxazolinforbindelser til bekæmpelse af fiskelus
NZ611476A (en) * 2010-12-27 2015-10-30 Intervet Int Bv Topical localized isoxazoline formulation
CN103260620A (zh) * 2010-12-27 2013-08-21 英特维特国际股份有限公司 包含三缩四乙二醇的外用局部异噁唑啉制剂
US20130324538A1 (en) 2011-02-10 2013-12-05 Noëlle Gauvry Isoxazoline derivatives for controlling invertebrate pests
SI2683723T1 (sl) 2011-03-10 2016-07-29 Zoetis Services Llc Spirociklični izoksazolinski derivati kot antiparazitiki
WO2013026695A1 (en) 2011-08-25 2013-02-28 Syngenta Participations Ag Isoxazoline derivatives as insecticidal compounds
CN103764644A (zh) 2011-08-25 2014-04-30 先正达参股股份有限公司 作为杀虫化合物的异噁唑啉衍生物
PT3172964T (pt) 2011-09-12 2020-11-30 Boehringer Ingelheim Animal Health Usa Inc Composições parasiticidas compreendendo um agente ativo de isoxazolina, método e utilizações das mesmas
US20140243375A1 (en) 2011-10-03 2014-08-28 Syngenta Participations Ag Isoxazoline derivatives as insecticidal compounds
BR112014024833B1 (pt) 2012-04-04 2022-10-04 Intervet International B.V. Produto farmacêutico veterinário mastigável macio, processo para sua fabricação e seu uso, bem como uso de pamoato de sódio
EP3052080B1 (en) 2013-09-30 2025-06-25 Zoetis Services LLC Long-acting spiro-isoxazoline formulations
JP6581586B2 (ja) 2013-12-20 2019-09-25 インターベット インターナショナル ベー. フェー. イソオキサゾリン組成物および動物における寄生虫侵襲の予防または処置におけるその使用
RU2688167C1 (ru) 2013-12-20 2019-05-20 Интервет Интернэшнл Б.В. Применение изоксазолиновых соединений на домашней птице

Also Published As

Publication number Publication date
HUE072822T2 (hu) 2025-12-28
EP3082867B1 (en) 2024-01-17
MX2016008118A (es) 2016-09-16
JP6581586B2 (ja) 2019-09-25
CN105813651B (zh) 2021-11-23
PL3082867T3 (pl) 2024-05-13
US20210353537A1 (en) 2021-11-18
US11883530B2 (en) 2024-01-30
EP3082867A1 (en) 2016-10-26
PL4306168T3 (pl) 2025-11-17
HUE066811T2 (hu) 2024-09-28
RU2688919C1 (ru) 2019-05-23
US20240122849A1 (en) 2024-04-18
CN110327468A (zh) 2019-10-15
US20160317439A1 (en) 2016-11-03
ES2971061T3 (es) 2024-06-03
CN105813651A (zh) 2016-07-27
US20200000720A1 (en) 2020-01-02
ES3036365T3 (en) 2025-09-18
CN110327468B (zh) 2023-04-28
PT4306168T (pt) 2025-07-24
EP4306168B1 (en) 2025-06-25
RU2016129474A (ru) 2018-01-25
US10456358B2 (en) 2019-10-29
EP4306168A3 (en) 2024-03-13
JP2016540809A (ja) 2016-12-28
RU2019114223A (ru) 2019-06-28
EP4306168A2 (en) 2024-01-17
WO2015091898A1 (en) 2015-06-25

Similar Documents

Publication Publication Date Title
EP4306168A3 (en) Isoxazoline compositions and use thereof in the prevention or treatment of parasite infestations in animals
CY1124726T1 (el) Παραγωγα κιναζολινης που χρησιμοποιουνται για την αντιμετωπιση του hiv
PH12019550050A1 (en) Isoxazole analogs as fxr agonists and methods of use thereof
CO2017002268A2 (es) Inhibidores espirocíclicos de catepsina c
MX387604B (es) Formulaciones cannabinoides estables.
MX2017008518A (es) Compuestos de isoquinolina para el tratamiento de virus de inmunodeficiencia humana (vih).
MX2018001990A (es) Composiciones que comprenden un inhibidor de p13k y un inhibidor de hdac.
DOP2015000274A (es) Compuestos químicos
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
GEP201706663B (en) Novel composition for nonalcoholic fatty liver disease (nafld
NZ712270A (en) Pharmaceutical composition of s-ketamine hydrochloride
MX2019005082A (es) Composiciones que comprenden 15-ohepa y metodos para usar las mismas.
PH12016502353A1 (en) Pharmaceutical composition
KR102200014B9 (ko) 쿠메스트롤을 포함하는 콩 추출물을 유효성분으로 포함하는 갱년기 증상의 예방 및 치료용 조성물
MX383254B (es) Combinacion que comprende un glucocorticoide y edo-s101.
EA201500821A1 (ru) Производные 2-замещенных-6-биарилметиламино-9-циклопентил-9н-пуринов, их использование в качестве лекарственных средств и фармацевтических составов
MX390051B (es) Antagonistas de ep4.
MX2017006709A (es) Agente para prevenir o mejorar sintomas causados por desequilibrio de las hormonas sexuales.
MX388592B (es) Compuestos y metodos terapeuticos.
UA115583C2 (uk) Азетидинілоксифенілпіролідинові сполуки
MX386902B (es) Metodos para el tratamiento de trastornos cardiovasculares.
PH12016502480A1 (en) Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases
TH1501006095A (th) องค์ประกอบของสารออกฤทธิ์ทางเภสัชกรรมที่ประกอบด้วย ไดเอธิลีน ไกลคอล โมโนเอธิล อีเธอร์ หรือ สารอนุพันธ์แอลคิลอื่นๆ

Legal Events

Date Code Title Description
FG Grant or registration